Skip to content

Clinical trials

Phase 4 Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 4 Clear all

73 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20022
20031
20041
20063
20073
20087
20093
20112
20122
20132
20144
20153
20163
20173
20183
20194
20201
20212
20225
20235
20245
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Recruiting12
Unknown status10
Terminated8
Withdrawn3
Not yet recruiting3
Suspended2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
CSA Medical, Inc.2
China Medical University, China2
Kaohsiung Medical University Chung-Ho Memorial Hospital2
Odense University Hospital2
Taipei Veterans General Hospital, Taiwan2
University Medical Center Groningen2
Alexandria University1
Amgen1
Assistance Publique - Hôpitaux de Paris1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms73
Carcinoma, Non-Small-Cell Lung18
Head and Neck Neoplasms5
Melanoma5
Breast Neoplasms4
Carcinoma, Renal Cell4
Neoplasms4
Ovarian Neoplasms4
Carcinoma, Hepatocellular3
Disease3

Trials

Showing 1 to 25 of 73. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.